Literature DB >> 11585638

LPS-induced IL-10 production in whole blood cultures from chronic fatigue syndrome patients is increased but supersensitive to inhibition by dexamethasone.

J Visser1, W Graffelman, B Blauw, I Haspels, E Lentjes, E R de Kloet, L Nagelkerken.   

Abstract

Several causes have been held responsible for the chronic fatigue syndrome (CFS), including an altered hypothalamus-pituitary-adrenal gland (HPA)-axis activity, viral infections and a reduced Th1 activity. Therefore, it was investigated whether the regulation of IL-10 is different in CFS. LPS-induced cytokine secretion in whole blood cultures showed a significant increase in IL-10 and a trend towards a decrease in IL-12 as compared with healthy controls. In patients and controls, IL-12 secretion was equally sensitive to suppression by dexamethasone, whereas IL-10 secretion appeared more sensitive in CFS-patients. In controls, IL-10 and IL-12 secretion were inversely correlated with free serum cortisol (r=-0.492, p<0.02 and r=-0.434, p<0.05, respectively). In CFS, such an inverse correlation was found for IL-12 (r=-0.611, p<0.02) but not for IL-10 (r=-0.341, ns). These data are suggestive for a disturbed glucocorticoid regulation of IL-10 in CFS.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11585638     DOI: 10.1016/s0165-5728(01)00400-3

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  10 in total

Review 1.  Evidence for the presence of immune dysfunction in chronic fatigue syndrome.

Authors:  Benjamin H Natelson; Mohammad H Haghighi; Nicholas M Ponzio
Journal:  Clin Diagn Lab Immunol       Date:  2002-07

2.  Severity of symptom flare after moderate exercise is linked to cytokine activity in chronic fatigue syndrome.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Lucinda Bateman; Thomas B Martins; Harry R Hill; Kathleen C Light
Journal:  Psychophysiology       Date:  2010-03-04       Impact factor: 4.016

Review 3.  Analysis of post COVID-19 condition and its overlap with myalgic encephalomyelitis/chronic fatigue syndrome.

Authors:  Olga A Sukocheva; Rebekah Maksoud; Narasimha M Beeraka; SabbaRao V Madhunapantula; Mikhail Sinelnikov; Vladimir N Nikolenko; Margarita E Neganova; Sergey G Klochkov; Mohammad Amjad Kamal; Donald R Staines; Sonya Marshall-Gradisnik
Journal:  J Adv Res       Date:  2021-11-26       Impact factor: 12.822

4.  High levels of type 2 cytokine-producing cells in chronic fatigue syndrome.

Authors:  A Skowera; A Cleare; D Blair; L Bevis; S C Wessely; M Peakman
Journal:  Clin Exp Immunol       Date:  2004-02       Impact factor: 4.330

5.  DNA methylation modifications associated with chronic fatigue syndrome.

Authors:  Wilfred C de Vega; Suzanne D Vernon; Patrick O McGowan
Journal:  PLoS One       Date:  2014-08-11       Impact factor: 3.240

6.  Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).

Authors:  Wilfred C de Vega; Santiago Herrera; Suzanne D Vernon; Patrick O McGowan
Journal:  BMC Med Genomics       Date:  2017-02-23       Impact factor: 3.063

7.  Reduction of Glucocorticoid Receptor Function in Chronic Fatigue Syndrome.

Authors:  Megan Lynn; Laura Maclachlan; Andreas Finkelmeyer; James Clark; James Locke; Stephen Todryk; Wan-Fai Ng; Julia L Newton; Stuart Watson
Journal:  Mediators Inflamm       Date:  2018-06-10       Impact factor: 4.711

8.  Ex vivo glucocorticoid receptor-mediated IL-10 response predicts the course of depression severity.

Authors:  Bernd Lenz; Christiane Mühle; Claudia von Zimmermann; Lea Böhm; Tanja Richter-Schmidinger; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2021-01-15       Impact factor: 3.575

9.  TRAF1-C5 affects quality of life in patients with primary biliary cirrhosis.

Authors:  Joanna Raszeja-Wyszomirska; Ewa Wunsch; Agnieszka Kempinska-Podhorodecka; Daniel S Smyk; Dimitrios P Bogdanos; Malgorzata Milkiewicz; Piotr Milkiewicz
Journal:  Clin Dev Immunol       Date:  2013-04-28

Review 10.  Neuroinflammation and Cytokines in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Critical Review of Research Methods.

Authors:  Michael B VanElzakker; Sydney A Brumfield; Paula S Lara Mejia
Journal:  Front Neurol       Date:  2019-01-10       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.